ArticleInternational journal of hematology2026

Talquetamab in Japanese patients with relapsed/refractory multiple myeloma in the MonumenTAL-1 study.

Shigeki Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.